Anthony Hunt, Director at REPLIGEN CORP (RGEN), sold 48,492 shares at $139.67 ($6.8M) on 2024-11-21, disclosed to the SEC on 2024-11-22.
Seasonal sale ($6.8M) by Director — this insider has traded RGEN in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $139.67 | 24,246 | $3.4M | 50.0% |
| 2 | $139.67 | 24,246 | $3.4M | 50.0% |
| Total | $139.67 avg | 48,492 | $6.8M | 100% |
| Filing → |
| RGEN | SELL | 2025-09-11 | $7.0M | — | Filing → |
| RGEN | SELL | 2025-05-16 | $6.5M | — | Filing → |
| RGEN | SELL | 2025-03-19 | $8.1M | — | Filing → |